The Division of Translational Neuroscience in Schizophrenia is focused on understanding the biological basis of schizophrenia and identifying new treatments for the several domains of symptoms. Current studies concentrate on exploring the role of hippocampal dysfunction in schizophrenia using in vivo imaging and human post-mortem tissue, exploring the phenotype associated with psychosis across all psychosis diagnoses, and testing early treatments for cognitive dysfunctions in the illness.
Emphasizing translational tools for clinical research, including human brain imaging and analysis of high quality human post-mortem tissue for hypothesis testing research, the range of clinical studies, from the most exploratory to highly applied clinical testing, is optimal for patient and normal volunteer recruitment from the community. It is a first-call resource for public mental health treatment centers around the city. In addition, the range of research activities attracts bright and talented students and associates to become involved in the research.
The Division of Translational Neuroscience of Schizophrenia research group’s mission is to focus on developing, supporting, and administering programs of research; research training and resource development aimed at understanding the pathophysiology of schizophrenia and related disorders; and hastening the translation of behavioral and neuroscience advances into innovations in clinical care.